People are using GLP-1s to cut back on alcohol use disorder, but there are already three FDA-approved drugs: naltrexone, acamprosate, and disulfiram.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

I was addicted to alcohol for more than 15 years. What started as binge drinking in high school and college became a pattern of blackouts, emergency room visits, regret and shame. As peers grew up and ...

Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

NEW YORK--(BUSINESS WIRE)--Oar Health, a virtual care platform offering FDA-approved medication to help people drink less or quit, today announced it has surpassed 50,000 patients served, a major ...

After becoming sober, the body follows a timeline healing: liver regeneration, blood pressure drops, cancer risk reduction ...

The liver is one of the most incredible organs in the human body. It acts as a primary filter, clearing out toxins and ...